IP Library Granted Patent US 9,487,788
Granted Patent B2
US 9,487,788 · App. 14/612,952 · Granted Nov 8, 2016

Patent

Inventors: James A. Williams (Lincoln, NE); Aaron E. Carnes (Lincoln, NE)
Assignee: Nature Technology Corporation
C12N15/73C12N1/06C12N15/1003C12N15/64
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,487,788
App. No.
14/612,952
Granted
Nov 8, 2016
Kind
B2
Abstract

General methods and strains of bacteria are described that dramatically simplify and streamline plasmid DNA production. In one preferred embodiment, endolysin mediated plasmid extraction combined with flocculation mediated removal of cell debris and host nucleic acids achieves increased yield and purity with simplified downstream purification and reduced waste streams, thus reducing production costs.

Claims (6)

1. A method for increasing production yield of a covalently closed, super-coiled plasmid DNA vector that is non-repetitive and does not contain direct repeats or long terminal repeats, comprising the steps of:

a. transforming a plasmid DNA vector that is non-repetitive and does not contain direct repeats or long terminal repeats into bacterial cells rendered competent for transformation; and

b. growing resultant transformed bacterial cells at a reduced temperature during colony isolation and colony amplification steps in order to create a cryopreserved seed stock for plasmid DNA vector production, the reduced temperature being approximately 20-33° C.;

whereby growth at said reduced temperature prior to cryopreservation improves said plasmid DNA vector yield in subsequent shake flask and or fermentation culture above yield that is achieved when growing the transformed bacterial cells at a temperature approximately 33-42° C. during colony isolation and colony amplification steps.

2. The method of claim 1 wherein said bacterial cells are Escherichia coli cells.

3. The method of claim 1 wherein said plasmid DNA vector that is non-repetitive and does not contain direct repeats or long terminal repeats is a DNA vaccine plasmid encoding an H1 or H3 serotype influenza hemagglutinin gene.

Assignments (2)
MERGER Recorded Feb 22, 2023
From: NATURE TECHNOLOGY CORPORATION
To: ALDEVRON, L.L.C.
Reel/Frame 062770/0971 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2019
From: WILLIAMS, JAMES A.; CARNES, AARON E.
To: NATURE TECHNOLOGY CORPORATION
Reel/Frame 049130/0186 →
Continuity (3)
Division 12601504
Provisional Application 60931465 · May 23, 2007
Related Publication 20150203854A1 · Jul 23, 2015